Psychosomatic Aspects of Low Adherence to Antihypertensive Therapy in Patients with Arterial Hypertension

Aim. To evaluate psychosomatic aspects of adherence to antihypertensive therapy (AHT) in patients with arterial hypertension and its relationships with comorbid somatic disturbances.Subjects and methods. A total of 161 patients with arterial hypertension with duration of more than 12 months (19 women, 42 men) aged 53,4±11,4 years were included in the study. All studied patients were followed up in the outpatient department of the Cardiology Research Institutenamed after A.L.Miasnikov, Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation, and were consented for the psychiatric examination. To evaluate the patient adherence to AHT the following questionnaires and scales have been used: original Complaint Questionnaire designed by the authors for patients with arterial hypertension, USK, USK-B, ORB, GOTD, and patient self-reported Morisky-Green medication adherence scale. Consistent with data of patient case histories and responses to questionnaires, studied subjects were classified into two groups of adherence levels to AHT: Group I - 30 (19%) subjects; 17 women/13 men; mean age 52,9±11,7 years - included patients with high adherence to AHT, who started medication right after being diagnosed for arterial hypertension, and were treated regularly. Group II - 131 (81%) subjects; 102 women/29 men; mean age 53,1±11,8 years - included patients with low adherence to AHT, with postponed initiation of AHT after the diagnosis, and irregular or absent treatment.Results and conclusions. Patients comprising Group I with high adherence to AHT were characterized by short duration of arterial hypertension, crisis-type of its onset followed by panic attacks; concomitant disorders (ischemic heart disease, arrhythmias, ulcer disease, thyroid gland abnormalities), high anxiety level, panic attacks, anxiety and phobic paroxysms, subclinical depressions (dysthymia, cyclothymia), anxiodepressivesituational adaptation reactions, and nozogenic (adaptive) anxiodepressive reactions (hypernozognosia). Patients comprising Group II with low adherence to AHT were characterized by more severe affective symptoms (depressive and maniacal phases of bipolar affective disorder and recurrent depressions) and different variants of pathocharacterologic personality development.

артериальная гипертония, приверженность антигипертензивной терапии, психосоматические аспекты приверженности терапии, arterial hypertension, adherence to antihypertensive therapy, psychosomatic aspects of adherence to medication

1. Wolf-Maier K, Cooper R.S, Kramer H. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10-7.

2. World Health Organisation: Adherence to long - term therapies, evidence for action. Geneva 2003; http://www.who.int2

3. Mazzaglia G, Ambrosioni E, Alacqua M. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120 (16): 1598-605.

4. Kulkarni S.P, Alexander K.P, Heiss G, Peterson E.D. Long - term adherence with cardiovascular drug regimens. Am Heart J 2006; 151 (1): 185-91.

5. Haynes R.B, Mc Kibbon K.A, Kanani R. Systematic review of randomized trials of interventions to assists patients to follow prescriptions for medications. Lancet 1996; 348: 383-6.

6. Чазов Е.И. Депрессивная симптоматика ухудшает прогноз у больных артериальной гипертонией и ишемической болезнью сердца: первые результаты проспективного этапа российского многоцентрового исследования КООРДИНАТА. Кардиология. 2007; 10: 24-30

7. Lichtman J.H, Bigger J.T, Blumenthal J.A. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. Circulation 2008; 118: 1768-75.

8. Оганов Р.Г., Погосова Г.В., Шальнова С.А., Деев А.Д. Депрессивные расстройства в общемедицинской практике по данным исследования КОМПАС: взгляд кардиолога. Кардиология. 2005; 8: 38-44.

9. Незнанов Н.Г., Вид В.Д. Проблема комплаенса в клинической психиатрии. Психиатрия и психофармакотерапия. 2004; 6(4): 159-62.

10. Briesacher B.A, Andrade S.E, Fouayzi H, Chan K.A. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008; 28 (4): 437-43.

11. Дробижев М.Ю. Нозогении (психогенные реакции) при соматических заболеваниях. Дис. ... д - ра мед. наук. М., 2000.

12. Kielholz P. (Hrsg) Die larvierte Depression. Huber, Bern, Stuttgart, Zurich, 1973.

13. Brautigam W., Christian P. Psychosomatische Medicin. Theime, Stuttgart, 1973.

14. Ясперс К. Общая психопатология. М.: Практика, 1997; с. 825-30.

15. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М., 2007; с. 61-2.

16. Смулевич А.Б. Психопатология личности и коморбидных расстройств. М., 2009; с. 116-8.

17. Ушаков Г.К. Пограничные нервно - психические расстройства. М.: Медицина, 1987; с. 206-12.

18. Лакосина Н.Д. Клинические варианты невротического развития. М.: Медицина, 1970.

19. Пограничная психиатрия. Под ред. Ю.А.Александровского. М., 2006; с. 6-12, 1260-2.

20. Alexander F. Psychosomatic medicine: Its principles and applications. New-York: Konald, 1951.

21. Лурия Р.А. Внутренняя картина болезней и ятрогенные заболевания. Изд. 4-е. М.: Медицина, 1977; с. 37-52.